EU Approval Of COVID-19 Vaccines Possible In Weeks

The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.

EU Coronavirus vaccine, Europe. Covid-19 vaccination, flu prevention, immunization concept. Vial dose and medical syringe, European Union flag background. 3d illustration
COVID-19 vaccines are nearing the market in Europe • Source: Shutterstock

The European Medicines Agency could decide within weeks whether the COVID-19 vaccines being developed by BioNTech/Pfizer and Moderna respectively should be granted pan-EU marketing approval.

Applications for the conditional marketing authorization (CMA) of BioNTech/Pfizer’s BNT162b2 and Moderna’s mRNA-1273 have now been received, the EMA said...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet